ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma

ClinicalTrials.gov ID: NCT01144455

Public ClinicalTrials.gov record NCT01144455. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Cross-over Phase 2 Study of the Safety and Efficacy of Two Dose Levels of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma

Study identification

NCT ID
NCT01144455
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ImmunoGenesis
Industry
Enrollment
214 participants

Conditions and interventions

Interventions

  • Gemzar (Gemcitabine) Drug
  • TH-302 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2010
Primary completion
Aug 31, 2013
Completion
Nov 30, 2014
Last update posted
May 10, 2025

2010 – 2014

United States locations

U.S. sites
59
U.S. states
29
U.S. cities
55
Facility City State ZIP Site status
Birmingham Hematology and Oncology Associates, LLC Birmingham Alabama 35223
Mayo Clinic Arizona Scottsdale Arizona 85259
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85704
University of Arizona Tucson Arizona 85724
Saint Edward Mercy Medical Center Fort Smith Arkansas 72917
Disney Family Cancer Center Burbank California 91505
Scripps Clinical Research Services La Jolla California 92037
UCLA Medical Center Los Angeles California 90095
Palo Alto Medical Foundation Mountain View California 94040
Los Palos Oncology and Hematology Salinas California 93901
Sharp Memorial Hospital San Diego California 92123
California Pacific Medical Center San Francisco California 94115
Rocky Mountain Cancer Centers Denver Colorado 80218
Hematology Oncology Associates, PC Stamford Connecticut 06902
Florida Cancer Institute - New Hope New Port Richey Florida 34655
Ocala Oncology Center Ocala Florida 34471
Martin Memorial Cancer Center Stuart Florida 34994
Atlanta Cancer Care Atlanta Georgia 30342
Loyola University Medical Center Maywood Illinois 60153
Carle Cancer Center Urbana Illinois 61901
Indiana University Melvin and Bren Simon Cancer Indianapolis Indiana 46202
Purchase Cancer Group Paducah Kentucky 42002
Medical Oncology Baton Rouge Louisiana 70809
Ochsner Cancer Institute New Orleans Louisiana 70121
LSU Health Sciences Center - Feist Weiller Cancer Center Shreveport Louisiana 71130
Massachusetts General Hospital Boston Massachusetts 02114
University of Massachusetts Medical Center Worcester Massachusetts 01655
Virgina Piper Cancer Institute Minneapolis Minnesota 55407
Mayo Clinic Rochester Rochester Minnesota 55905
Hematology and Oncology Associates at BridgePoint Tupelo Mississippi 38801
Missouri Cancer Associates Columbia Missouri 65201
Montana Cancer Institute Foundation Missoula Montana 59802
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
Roswell Park Cancer Institute Buffalo New York 14263
New York Oncology Hematology, P.C. Hudson New York 12534
Cancer Care of Western North Carolina, PA Asheville North Carolina 28801
Alamance Oncology Hematolgy Associates Burlington North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Carolina Oncology Specialists, PA Hickory North Carolina 28602
Emerywood Hematology and Oncology High Point North Carolina 27262
Signal Point Clinical Research Center Middletown Ohio 45042
Kaiser Permanente Northwest Region Oncology Hematology Portland Oregon 97227
Northwest Cancer Specialists, P.C. Portland Oregon 97227
Greater Philadelphia Cancer and Hematology Specialists, P.C. Philadelphia Pennsylvania 19114
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232
Institute for Translational Oncology Research (ITOR) Greenville South Carolina 29605
Vanderbilt University Medical Center, Div. of Medical Oncology Nashville Tennessee 37232
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center Beaumont Texas 77702
Texas Oncology-Dallas Presbyterian Hospital Dallas Texas 75231
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75390
Texas Oncology- Fort Worth - 12th Avenue Fort Worth Texas 76104
Texas Oncology-Seton Williamson Round Rock Texas 78665
Texas Oncology-Sherman Sherman Texas 75090
Texas Oncology-Wichita Falls Texoma Cancer Center Wichita Falls Texas 76310
Fairfax Northern Virginia Hematology Oncology, PC Fairfax Virginia 22031
Providence Everett Regional Medical Center, Cancer Research Dept. Everett Washington 98201
Columbia Basin Hematology and Oncology0 Kennewick Washington 99336
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01144455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01144455 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →